Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial

Xiaomei Leng, Piotr Leszczyński, Sławomir Jeka, Shengyun Liu, Huaxiang Liu, Małgorzata Miakisz, Jieruo Gu, L. Kilasonia, Mykola Stanislavchuk, Xiaolei Yang, Yinbo Zhou, Qingfeng Dong, Mourad F. Rezk, Marian Mitroiu, Janet Addison, Xiaofeng Zeng